Stallergenes Greer U.S. Revenue and Competitors
Estimated Revenue & Valuation
- Stallergenes Greer U.S.'s estimated annual revenue is currently $9.4M per year.
- Stallergenes Greer U.S.'s estimated revenue per employee is $201,000
Employee Data
- Stallergenes Greer U.S. has 47 Employees.
- Stallergenes Greer U.S. grew their employee count by 4% last year.
Stallergenes Greer U.S.'s People
| Name | Title | Email/Phone |
|---|
Stallergenes Greer U.S. Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $413.3M | 324 | 0% | $634M | N/A |
#2 | $47.8M | 238 | 0% | N/A | N/A |
#3 | $2.4M | 12 | -52% | N/A | N/A |
#4 | $25.7M | 128 | 39% | N/A | N/A |
#5 | $12.9M | 64 | 129% | N/A | N/A |
#6 | $23.9M | 119 | 8% | $113M | N/A |
#7 | $0.3M | 3 | 0% | N/A | N/A |
#8 | $10.3M | 51 | -14% | N/A | N/A |
#9 | $1.8M | 367 | -4% | $538M | N/A |
#10 | $50M | 249 | 3% | N/A | N/A |
What Is Stallergenes Greer U.S.?
Headquartered in Boston, MA with locations in Lenoir, NC and San Diego, CA, Stallergenes Greer’s business in the United States is part of a leading global biopharmaceutical company specializing in the development and commercialization of allergy immunotherapy (AIT) products and services for use in the diagnosis and treatment of allergies.
keywords:N/A
N/A
Total Funding
47
Number of Employees
$9.4M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.5M | 47 | -4% | N/A |
#2 | $5.5M | 47 | N/A | N/A |
#3 | $4.6M | 47 | 0% | N/A |
#4 | $7.2M | 47 | -11% | $15M |
#5 | $5.5M | 47 | 7% | N/A |